Label: EQUALINE ESOMEPRAZOLE MAGNESIUM- esomeprazole capsule, delayed release
- NDC Code(s): 41163-539-01, 41163-539-02, 41163-539-03
- Packager: Supervalu Inc
- Category: HUMAN OTC DRUG LABEL
Drug Label Information
Updated October 4, 2021
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient (in each capsule)
- Purpose
- Uses
- Warnings
- Ask a doctor before use if you have
- Ask a doctor or pharmacist before use if you are
- Stop use and ask a doctor if
- If pregnant or breast-feeding,
- Keep out of reach of children.
-
Directions
- •
- adults 18 years of age and older
- •
- this product is to be used once a day (every 24 hours), every day for 14 days
- •
- may take 1 to 4 days for full effect
14-Day Course of Treatment
- •
- swallow 1 capsule with a glass of water before eating in the morning
- •
- take every day for 14 days
- •
- do not take more than 1 capsule a day
- •
- swallow whole. Do not crush or chew capsules.
- •
- do not use for more than 14 days unless directed by your doctor
Repeated 14-Day Courses (if needed)
- •
- you may repeat a 14-day course every 4 months
- •
- do not take for more than 14 days or more often than every 4 months unless directed by a doctor
- •
- children under 18 years of age: ask a doctor before use. Heartburn in children may sometimes be caused by a serious condition.
- Other information
-
Inactive ingredients
FD&C blue no. 1, FD&C red no. 3, ferric oxide, gelatin, glyceryl monostearate, hypromellose, magnesium stearate, meglumine, methacrylic acid and ethyl acrylate copolymer dispersion, polyethylene glycol, polysorbate 80, shellac, sodium lauryl sulfate, sugar spheres, talc, titanium dioxide, triethyl citrate
- Questions or comments?
- Package/Label Principal Display Panel
-
INGREDIENTS AND APPEARANCE
EQUALINE ESOMEPRAZOLE MAGNESIUM
esomeprazole capsule, delayed releaseProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:41163-539 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ESOMEPRAZOLE (UNII: N3PA6559FT) (ESOMEPRAZOLE - UNII:N3PA6559FT) ESOMEPRAZOLE 20 mg Inactive Ingredients Ingredient Name Strength FD&C BLUE NO. 1 (UNII: H3R47K3TBD) FD&C RED NO. 3 (UNII: PN2ZH5LOQY) FERRIC OXIDE RED (UNII: 1K09F3G675) GELATIN, UNSPECIFIED (UNII: 2G86QN327L) GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4) HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) MAGNESIUM STEARATE (UNII: 70097M6I30) MEGLUMINE (UNII: 6HG8UB2MUY) POLYSORBATE 80 (UNII: 6OZP39ZG8H) SODIUM LAURYL SULFATE (UNII: 368GB5141J) TALC (UNII: 7SEV7J4R1U) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) TRIETHYL CITRATE (UNII: 8Z96QXD6UM) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) SHELLAC (UNII: 46N107B71O) Product Characteristics Color BLUE (opaque) Score no score Shape CAPSULE (oblong) Size 14mm Flavor Imprint Code L898 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:41163-539-01 1 in 1 CARTON 09/25/2017 1 14 in 1 BOTTLE; Type 0: Not a Combination Product 2 NDC:41163-539-02 2 in 1 CARTON 03/06/2018 03/01/2021 2 14 in 1 BOTTLE; Type 0: Not a Combination Product 3 NDC:41163-539-03 3 in 1 CARTON 02/28/2018 03/01/2021 3 14 in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207193 09/25/2017 Labeler - Supervalu Inc (006961411)